BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tutton MG, George ML, Eccles SA, Burton S, Swift RI, Abulafi AM. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer. 2003;107:541-550. [PMID: 14520690 DOI: 10.1002/ijc.11436] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Delektorskaya VV, Kushlinskii NE. Clinical Significance of the Content of Biomolecular Markers in Invasive Front of Colon Carcinomas. Bull Exp Biol Med 2011;150:368-71. [DOI: 10.1007/s10517-011-1144-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lin CY, Lee CH, Huang CC, Lee ST, Guo HR, Su SB. Impact of high glucose on metastasis of colon cancer cells. World J Gastroenterol 2015; 21(7): 2047-2057 [PMID: 25717237 DOI: 10.3748/wjg.v21.i7.2047] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
3 Worthley DL, Giraud AS, Wang TC. The extracellular matrix in digestive cancer. Cancer Microenviron 2010;3:177-85. [PMID: 21209783 DOI: 10.1007/s12307-010-0053-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 He S, Wei YZ, Wang GL, Xu YY, Zhou JM, Zhang YX, Chen L. Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo. Gastroenterol Res Pract 2013;2013:685150. [PMID: 24307893 DOI: 10.1155/2013/685150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
5 Lin D, Tseng C, Lim QF, Tan MJ, Kong KV. A rapid and highly sensitive strain-effect graphene-based bio-sensor for the detection of stroke and cancer bio-markers. J Mater Chem B 2018;6:2536-40. [DOI: 10.1039/c8tb00404h] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Gordon MR, Zhao B, Anson F, Fernandez A, Singh K, Homyak C, Canakci M, Vachet RW, Thayumanavan S. Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake. Biomacromolecules 2018;19:860-71. [PMID: 29360342 DOI: 10.1021/acs.biomac.7b01659] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
7 Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005; 11(10): 1445-1451 [PMID: 15770719 DOI: 10.3748/wjg.v11.i10.1445] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
8 Koss KM, Tsui C, Unsworth LD. Enzymatic Activity in Fractal Networks of Self-Assembling Peptides. Biomacromolecules 2019;20:422-34. [DOI: 10.1021/acs.biomac.8b01496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Federico A, Dallio M, Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules 2017;22:E191. [PMID: 28125040 DOI: 10.3390/molecules22020191] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 26.4] [Reference Citation Analysis]
10 Ai Y, Zhao Z, Wang H, Zhang X, Qin W, Guo Y, Zhao M, Tang J, Ma X, Zeng J. Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy. Phytotherapy Research. [DOI: 10.1002/ptr.7492] [Reference Citation Analysis]
11 Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis. 2005;20:245-252. [PMID: 15592677 DOI: 10.1007/s00384-004-0667-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
12 Gong T, Kong KV, Goh D, Olivo M, Yong KT. Sensitive surface enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers. Biomed Opt Express 2015;6:2076-87. [PMID: 26114030 DOI: 10.1364/BOE.6.002076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
13 Hawkins RE, Daigneault L, Cowan R, Griffiths R, Panchal C, Armstrong A, Fenemore J, Irvine A, Sereda K, Dulude H. Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer. Clinical Prostate Cancer 2005;4:91-9. [DOI: 10.3816/cgc.2005.n.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
14 Delektorskaya VV, Golovkov DA, Kushlinskii NE. Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer. Bull Exp Biol Med 2008;146:616-9. [PMID: 19526105 DOI: 10.1007/s10517-009-0343-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Chen X, Qi S, Li Z, He B, Li HL, Fu J, Huang S, Zhang L, Li X, Hu R, Li L, Wang T, Xue F, Gao X, Shi X, Zhang T, Wang X, Wang J, Ding Z. Shenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique. Biomed Res Int 2019;2019:8084109. [PMID: 31179333 DOI: 10.1155/2019/8084109] [Reference Citation Analysis]
16 Deakin NE, Chaplain MA. Mathematical modeling of cancer invasion: the role of membrane-bound matrix metalloproteinases. Front Oncol 2013;3:70. [PMID: 23565505 DOI: 10.3389/fonc.2013.00070] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
17 Yang SF, Hsieh YS, Lin CL, Hsu NY, Chiou HL, Chou FP, Chu SC. Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clin Chim Acta 2005;354:91-9. [PMID: 15748604 DOI: 10.1016/j.cccn.2004.11.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
18 Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, Deangelis LM, Holland EC, Hormigo A. Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. J Neurooncol 2011;105:607-12. [PMID: 21710351 DOI: 10.1007/s11060-011-0628-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ung L, Lam AK, Morris DL, Chua TC. Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review. Clin Transl Oncol. 2014;16:425-435. [PMID: 24458880 DOI: 10.1007/s12094-013-1154-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
20 Auyeung KK, Law PC, Ko JK. Combined therapeutic effects of vinblastine and Astragalus saponins in human colon cancer cells and tumor xenograft via inhibition of tumor growth and proangiogenic factors. Nutr Cancer. 2014;66:662-674. [PMID: 24660995 DOI: 10.1080/01635581.2014.894093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
21 Bassik N, Brafman A, Zarafshar AM, Jamal M, Luvsanjav D, Selaru FM, Gracias DH. Enzymatically triggered actuation of miniaturized tools. J Am Chem Soc 2010;132:16314-7. [PMID: 20849106 DOI: 10.1021/ja106218s] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
22 Andrés NC, Fermento ME, Gandini NA, Romero AL, Ferro A, Donna LG, Curino AC, Facchinetti MM. Heme oxygenase-1 has antitumoral effects in colorectal cancer: involvement of p53. Exp Mol Pathol 2014;97:321-31. [PMID: 25236576 DOI: 10.1016/j.yexmp.2014.09.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
23 Jonsson A, Hjalmarsson C, Falk P, Ivarsson ML. Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer. Br J Cancer 2016;115:703-6. [PMID: 27187685 DOI: 10.1038/bjc.2016.127] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
24 Kolliopoulos C, Bounias D, Bouga H, Kyriakopoulou D, Stavropoulos M, Vynios DH. Hyaluronidases and their inhibitors in the serum of colorectal carcinoma patients. J Pharm Biomed Anal 2013;83:299-304. [PMID: 23777618 DOI: 10.1016/j.jpba.2013.05.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
25 Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287-5297. [PMID: 19738110 DOI: 10.1200/JCO.2009.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Heidemann J, Binion DG, Domschke W, Kucharzik T. Antiangiogenic therapy in human gastrointestinal malignancies. Gut 2006;55:1497-511. [PMID: 16966704 DOI: 10.1136/gut.2005.088229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
27 Jonsson A, Hjalmarsson C, Falk P, Ivarsson ML. Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer. Med Oncol 2018;35:50. [PMID: 29520667 DOI: 10.1007/s12032-018-1109-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Cao LL, Pei XF, Qiao X, Yu J, Ye H, Xi CL, Wang PY, Gong ZL. SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells. Dig Dis Sci. 2018;63:2309-2319. [PMID: 29855767 DOI: 10.1007/s10620-018-5137-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
29 Cavdar Z, Canda AE, Terzi C, Sarioglu S, Fuzun M, Oktay G. Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer. Colorectal Dis 2011;13:154-60. [PMID: 19888958 DOI: 10.1111/j.1463-1318.2009.02105.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
30 God JM, Tate P, Larcom LL. Anticancer Effects of Four Varieties of Muscadine Grape. Journal of Medicinal Food 2007;10:54-9. [DOI: 10.1089/jmf.2006.699] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
31 Sun X, Zhang J, Yang C, Huang Z, Shi M, Pan S, Hu H, Qiao M, Chen D, Zhao X. Dual-Responsive Size-Shrinking Nanocluster with Hierarchical Disassembly Capability for Improved Tumor Penetration and Therapeutic Efficacy. ACS Appl Mater Interfaces 2019;11:11865-75. [DOI: 10.1021/acsami.8b21580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
32 Emara M, Cheung PY, Grabowski K, Sawicki G, Wozniak M. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clin Chem Lab Med. 2009;47:993-1000. [PMID: 19569980 DOI: 10.1515/cclm.2009.212] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
33 Suresh AK, Weng Y, Li Z, Zerda R, Van Haute D, Williams JC, Berlin JM. Matrix metalloproteinase-triggered denuding of engineered gold nanoparticles for selective cell uptake. J Mater Chem B 2013;1:2341. [DOI: 10.1039/c3tb00435j] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
34 Dong QZ, Zhao Y, Liu Y, Wang Y, Zhang PX, Jiang GY, Dong XJ, Cui QZ, Wang EH. Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Sci 2010;101:1562-9. [PMID: 20398053 DOI: 10.1111/j.1349-7006.2010.01557.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
35 Vinnakota K, Zhang Y, Selvanesan BC, Topi G, Salim T, Sand-Dejmek J, Jönsson G, Sjölander A. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases. J Cell Physiol 2017;232:3468-80. [PMID: 28098359 DOI: 10.1002/jcp.25808] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 10.2] [Reference Citation Analysis]
36 Glasgow CG, Steagall WK, Taveira-Dasilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, Moses M, Darling T, Moss J. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med 2010;104 Suppl 1:S45-58. [PMID: 20630348 DOI: 10.1016/j.rmed.2010.03.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
37 Shantha Kumara H, Yan XH, Pettke E, Cekic V, Gandhi ND, Bellini GA, Whelan RL. Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection. World J Gastrointest Oncol 2019; 11(6): 470-488 [PMID: 31236198 DOI: 10.4251/wjgo.v11.i6.470] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
38 Oh G, Yoo SW, Jung Y, Ryu YM, Park Y, Kim SY, Kim KH, Kim S, Myung SJ, Chung E. Intravital imaging of mouse colonic adenoma using MMP-based molecular probes with multi-channel fluorescence endoscopy. Biomed Opt Express. 2014;5:1677-1689. [PMID: 24877024 DOI: 10.1364/BOE.5.001677] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
39 Augsten M, Hägglöf C, Peña C, Ostman A. A digest on the role of the tumor microenvironment in gastrointestinal cancers. Cancer Microenviron 2010;3:167-76. [PMID: 21209782 DOI: 10.1007/s12307-010-0040-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
40 Szczepaniak A, Fichna J, Zielińska M. Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer. Curr Treat Options Oncol 2020;21:6. [PMID: 31970561 DOI: 10.1007/s11864-019-0699-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Isaacson KJ, Martin Jensen M, Subrahmanyam NB, Ghandehari H. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. J Control Release 2017;259:62-75. [PMID: 28153760 DOI: 10.1016/j.jconrel.2017.01.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
42 Choi JH, Lee JS, Park KM, Bae JW, Lee Y, Park KD. Multi-layered nanogels with MMP-sheddable PEG masks: Preparation and promotion of tumor cell uptake by controlling surface characteristics. Colloids and Surfaces B: Biointerfaces 2017;156:71-8. [DOI: 10.1016/j.colsurfb.2017.05.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
43 de Sousa Neto IV, Durigan JLQ, Guzzoni V, Tibana RA, Prestes J, de Araujo HSS, Marqueti RC. Effects of Resistance Training on Matrix Metalloproteinase Activity in Skeletal Muscles and Blood Circulation During Aging. Front Physiol 2018;9:190. [PMID: 29593554 DOI: 10.3389/fphys.2018.00190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
44 Nazli C, Demirer GS, Yar Y, Acar HY, Kizilel S. Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs). Colloids Surf B Biointerfaces 2014;122:674-83. [PMID: 25183059 DOI: 10.1016/j.colsurfb.2014.07.049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
45 Jensen SA, Vainer B, Bartels A, Brünner N, Sørensen JB. Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome. Eur J Cancer. 2010;46:3233-3242. [PMID: 20801641 DOI: 10.1016/j.ejca.2010.07.046] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
46 Nisiewicz MK, Kowalczyk A, Gajda A, Kasprzak A, Bamburowicz-Klimkowska M, Grudzinski IP, Nowicka AM. Enzymatic cleavage of specific dipeptide conjugated with ferrocene as a flexible ultra-sensitive and fast voltammetric assay of matrix metalloproteinase-9 considered a prognostic cancer biomarker in plasma samples. Biosens Bioelectron 2022;195:113653. [PMID: 34563889 DOI: 10.1016/j.bios.2021.113653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Angenete E, Langenskiöld M, Falk P, Ivarsson ML. Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation. Int J Colorectal Dis 2007;22:667-74. [PMID: 17109104 DOI: 10.1007/s00384-006-0225-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
48 Tang XP, Tang GD, Fang CY. Metformin inhibits cell migration in human pancreatic cancer cell line Bxpc-3. Shijie Huaren Xiaohua Zazhi 2012; 20(16): 1468-1472 [DOI: 10.11569/wcjd.v20.i16.1468] [Reference Citation Analysis]
49 Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S, Murray GI. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol 2012;228:471-81. [PMID: 22450763 DOI: 10.1002/path.4031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
50 Tokarzewicz A, Romanowicz L, Sveklo I, Matuszczak E, Hermanowicz A, Gorodkiewicz E. SPRI biosensors for quantitative determination of matrix metalloproteinase-2. Anal Methods 2017;9:2407-14. [DOI: 10.1039/c7ay00786h] [Cited by in Crossref: 18] [Article Influence: 3.6] [Reference Citation Analysis]
51 Gimeno-García AZ, Santana-Rodríguez A, Jiménez A, Parra-Blanco A, Nicolás-Pérez D, Paz-Cabrera C, Díaz-González F, Medina C, Díaz-Flores L, Quintero E. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur J Cancer. 2006;42:3246-3252. [PMID: 16973348 DOI: 10.1016/j.ejca.2006.06.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
52 Boonsongserm P, Angsuwatcharakon P, Puttipanyalears C, Aporntewan C, Kongruttanachok N, Aksornkitti V, Kitkumthorn N, Mutirangura A. Tumor-induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncol Lett 2019;18:3039-48. [PMID: 31452782 DOI: 10.3892/ol.2019.10638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
53 Pezeshkian Z, Nobili S, Peyravian N, Shojaee B, Nazari H, Soleimani H, Asadzadeh-Aghdaei H, Ashrafian Bonab M, Nazemalhosseini-Mojarad E, Mini E. Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer. Cancers (Basel) 2021;13:6226. [PMID: 34944846 DOI: 10.3390/cancers13246226] [Reference Citation Analysis]
54 Gao L, Mbonu N, Cao L, Gao D. Label-Free Colorimetric Detection of Gelatinases on Nanoporous Silicon Photonic Films. Anal Chem 2008;80:1468-73. [DOI: 10.1021/ac701870y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
55 Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287-5297. [PMID: 19738110 DOI: 10.1200/jco.2009.23.5556] [Cited by in Crossref: 533] [Cited by in F6Publishing: 265] [Article Influence: 41.0] [Reference Citation Analysis]
56 Nambiar J, Bose C, Venugopal M, Banerji A, Patel TB, Kumar GB, Nair BG. Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK. Exp Cell Res 2016;349:139-51. [PMID: 27737732 DOI: 10.1016/j.yexcr.2016.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
57 Cho Y, Kim H, Turner ND, Mann JC, Wei J, Taddeo SS, Davidson LA, Wang N, Vannucci M, Carroll RJ, Chapkin RS, Lupton JR. A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis. J Nutr 2011;141:1029-35. [PMID: 21508209 DOI: 10.3945/jn.110.134973] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
58 Medina C, Santana A, Quintero E, Radomski M, Guarner F. Metaloproteinasas de matriz en enfermedades del tracto gastrointestinal. Gastroenterología y Hepatología 2004;27:491-7. [DOI: 10.1016/s0210-5705(03)70509-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Ben Néjima D, Ben Zarkouna Y, Pujol P, Gammoudi A, Boussen H, Manai M. Clinicopathologic and Prognostic Significance of Gelatinase A in Tunisian Colorectal Cancer: A Case-Control Study. Appl Immunohistochem Mol Morphol 2017;25:64-70. [PMID: 27922483 DOI: 10.1097/PAI.0000000000000263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Patil R, Mahajan A, Pradeep GL, Prakash N, Patil S, Khan SM. Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol 2021;25:239-46. [PMID: 34703116 DOI: 10.4103/0973-029X.325121] [Reference Citation Analysis]
61 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
62 Davis MT, Auger P, Spahr C, Patterson SD. Cancer biomarker discovery via low molecular weight serum proteome profiling - Where is the tumor? Proteomics Clin Appl 2007;1:1545-58. [PMID: 21136654 DOI: 10.1002/prca.200700141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
63 Ramadass SK, Anantharaman NV, Subramanian S, Sivasubramanian S, Madhan B. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells. Colloids Surf B Biointerfaces 2015;125:65-72. [PMID: 25437065 DOI: 10.1016/j.colsurfb.2014.11.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
64 Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer 2005;116:422-7. [PMID: 15818624 DOI: 10.1002/ijc.21092] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
65 Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T. Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination. Hum Vaccin Immunother 2015;11:2784-9. [PMID: 26325075 DOI: 10.1080/21645515.2015.1075107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
66 Nisiewicz MK, Kowalczyk A, Sikorska M, Kasprzak A, Bamburowicz-Klimkowska M, Koszytkowska-Stawińska M, Nowicka AM. Poly(amidoamine) dendrimer immunosensor for ultrasensitive gravimetric and electrochemical detection of matrix metalloproteinase-9. Talanta 2022;247:123600. [PMID: 35659686 DOI: 10.1016/j.talanta.2022.123600] [Reference Citation Analysis]
67 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(11): 2674-2678 [DOI: 10.11569/wcjd.v12.i11.2674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 2007;29:564-72. [PMID: 17252594 DOI: 10.1002/hed.20561] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
69 Ryu JS, Kratz F, Raucher D. Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study. Int J Mol Sci 2021;22:1126. [PMID: 33498762 DOI: 10.3390/ijms22031126] [Reference Citation Analysis]
70 Omran OM, Thabet M. Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study. Ultrastruct Pathol 2012;36:108-16. [PMID: 22471433 DOI: 10.3109/01913123.2011.641671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
71 Waas ET, Hendriks T, Lomme RMLM, Wobbes T. Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients. Diseases of the Colon & Rectum 2005;48:700-10. [DOI: 10.1007/s10350-004-0854-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
72 Zhang ML, Xu JM, Mei Q, Bao JJ. Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 protein in colonic carcinoma. Shijie Huaren Xiaohua Zazhi 2005; 13(20): 2494-2497 [DOI: 10.11569/wcjd.v13.i20.2494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Dettling DE, Kwok E, Quach L, Datt A, Degenhardt JD, Panchal A, Seto P, Krakow JL, Wall R, Hillier BJ, Zhu Y, Vinogradova M, DuBridge RB, May C. Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186. J Immunother Cancer 2022;10:e004336. [PMID: 35728872 DOI: 10.1136/jitc-2021-004336] [Reference Citation Analysis]
74 Jonsson A, Falk P, Angenete E, Hjalmarsson C, Ivarsson ML. Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer. J Surg Res 2021;266:254-60. [PMID: 34034060 DOI: 10.1016/j.jss.2021.04.021] [Reference Citation Analysis]
75 Ohtani H, Maeda N and Murawaki Y. Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNF-alpha Genes, and the risk of colorectal neoplasm in Japanese. Yonago Acta Med. 2009;52:47-56. [PMID: 15485653 DOI: 10.1016/j.bbrc.2004.09.150] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
76 Liu F, Chen R, Song W, Li L, Lei C, Nie Z. Modular Combination of Proteolysis-Responsive Transcription and Spherical Nucleic Acids for Smartphone-Based Colorimetric Detection of Protease Biomarkers. Anal Chem 2021;93:3517-25. [DOI: 10.1021/acs.analchem.0c04894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
77 Gimeno-García AZ, Triñanes J, Quintero E, Salido E, Nicolás-Pérez D, Adrián-de-Ganzo Z, Alarcón-Fernández O, Abrante B, Romero R, Carrillo M, Ramos L, Alonso I, Ortega J, Jiménez A. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia. Gastroenterol Hepatol 2016;39:433-41. [PMID: 26601990 DOI: 10.1016/j.gastrohep.2015.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
78 Renò F, Traina V, Cannas M. Adsorption of matrix metalloproteinases onto biomedical polymers: a new aspect in biological acceptance. J Biomater Sci Polym Ed 2008;19:19-29. [PMID: 18177551 DOI: 10.1163/156856208783227631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
79 Chen Y, Shang H, Zhang S, Zhang X. Retracted : Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down‐regulation of microRNA‐31. J Cell Biochem 2018;119:6527-34. [DOI: 10.1002/jcb.26716] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
80 Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 2013; 19(10): 1582-1592 [PMID: 23538603 DOI: 10.3748/wjg.v19.i10.1582] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
81 Mao W, Kim HS, Son YJ, Kim SR, Yoo HS. Doxorubicin encapsulated clicked gold nanoparticle clusters exhibiting tumor-specific disassembly for enhanced tumor localization and computerized tomographic imaging. J Control Release 2018;269:52-62. [PMID: 29113793 DOI: 10.1016/j.jconrel.2017.11.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
82 Shah SA, Spinale FG, Ikonomidis JS, Stroud RE, Chang EI, Reed CE. Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung. J Thorac Cardiovasc Surg 2010;139:984-90; discussion 990. [PMID: 20304142 DOI: 10.1016/j.jtcvs.2009.12.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]